Bliss GVS Pharma Limited — Important, 07-01-2025: Updates

The ESOP Allotment Committee of Bliss GVS Pharma Limited has approved the allocation of 4,000 equity shares under the Employee Stock Option Plan 2019. Following this allotment, the company's issued, subscribed, and paid-up share capital has risen to Rs. 10,53,70,272, with the total number of equity shares increasing from 10,53,66,273 to 10,53,70,272. The shares were issued at an exercise price of Rs. 43 per share, with a premium of Rs. 42 per share. There will be a lock-in period of six months on these shares, set to expire on July 07, 2025. This development signals a commitment to employee engagement and retention, potentially enhancing future company performance. Investors should monitor this move as it may reflect positively on organizational morale and operational efficiency.